🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Arteris CEO Charles Janac sells shares worth over $137,000

Published 07/03/2024, 06:30 PM
AIP
-

Arteris, Inc. (NASDAQ:AIP) President and CEO Charles K. Janac has recently sold a portion of his holdings in the company. According to a recent filing with the Securities and Exchange Commission, Janac sold shares over the course of three days, with transactions totaling over $137,000.

The sales occurred on July 1st, 2nd, and 3rd, with the highest average price per share reaching $7.2401 and the lowest at $6.9795. On July 1st, Janac sold 4,583 shares at an average price of $7.2401, followed by two separate sales of 2,760 shares each on July 2nd at $6.9795. The final sale on July 3rd involved 9,168 shares at an average price of $7.2284.

The total value of shares sold at the higher price range on July 1st and 3rd amounted to $99,451, while the transactions on July 2nd totaled $38,526. These sales were made under a 10b5-1 trading plan, which allows company insiders to set up a predetermined schedule for selling stocks at a time when they are not in possession of material non-public information.

The SEC filing also included information about indirect holdings through entities such as Bayview Legacy, LLC, and the Charles & Lydia Janac Trust, indicating a broader scope of Janac's interests in Arteris beyond his direct ownership.

While the transactions represent a change in Janac's personal stake, they do not necessarily indicate a shift in the company's performance or outlook. Investors often monitor insider sales for insights into executive sentiment but are also aware that such sales can be part of regular financial planning or diversification strategies.

Arteris, Inc. specializes in semiconductor and related devices, a sector that continues to be a significant component of the global technology landscape.

In other recent news, Arteris, Inc. reported a robust start to the year with an annual contract value plus royalties of $58.2 million for Q1, despite a slight year-over-year decline in total revenue. The company also reported positive free cash flow and secured several significant licensing deals, half of which enable AI and machine learning designs. In terms of analyst ratings, Northland maintained its Outperform rating on Arteris, signaling confidence in the company's strategic direction.

In addition, Arteris is enhancing its collaboration with Esperanto Technologies, a high-performance, energy-efficient AI, and high-performance computing solutions provider. This partnership aims to streamline the design process for Esperanto's next-generation AI and HPC SoCs, with Arteris' CSRCompiler software playing a crucial role.

These recent developments highlight Arteris' commitment to financial health and its strategic initiatives to capitalize on the growing demand for sophisticated AI chips. Furthermore, they underscore the company's position as a leader in SoC integration automation and its role in the fast-evolving SoC market.

InvestingPro Insights

Arteris, Inc. (NASDAQ:AIP) has been navigating the semiconductor landscape with a strong balance sheet, as evidenced by the company holding more cash than debt. This financial stability is a crucial factor for investors considering the volatile nature of the tech industry. Moreover, Arteris boasts an impressive gross profit margin of nearly 90%, as per the last twelve months ending Q1 2024, which highlights the company's ability to maintain profitability in its core operations despite broader market challenges.

However, it's worth noting that analysts do not expect Arteris to be profitable this year, and the company has not been profitable over the last twelve months. This could be a point of concern for investors looking for immediate returns, but those with a long-term perspective might see potential in the company's high gross profit margins and recent price uptick. Over the last six months, the company's stock has seen a significant increase of 33.27%, which could indicate growing investor confidence or a response to positive developments within the company or sector.

For those interested in a deeper dive into Arteris' financials and performance metrics, InvestingPro offers a comprehensive analysis, including additional InvestingPro Tips that can help inform investment decisions. Use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription. With these insights, investors can better assess the potential risks and rewards of investing in Arteris, Inc.

For more detailed information and to uncover the full range of InvestingPro Tips, visit https://www.investing.com/pro/AIP. There are 7 additional tips available that can provide further guidance on Arteris' investment profile.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.